MDCG guidance clarifies requirements for AI products under AI Act, MDR, and IVDR | RAPS
It states that medical device artificial intelligence (MDAI) products are considered high risk if they have a safety component or their AI system is ...
- Topics
- Regulation & PolicyAI Safety & Existential RiskHealthcare
- Mentions
- EU AI Act
- Tracked via
- “AI Risks”